C2 Therapeutics
develops ablation therapies to treat gastrointestinal diseases... Read moreC2 Therapeutics
develops ablation therapies to treat gastrointestinal diseases... Read more
News
May 08, 2017
Blackbird
Press Release: C2 Therapeutics : Studies Further Validate Safety, Efficacy And An Improved Patient Experience In Use Of The C2 CryoBalloon® Ablation System For Primary Treatment Of Barrett's Esophagus
Jan 11, 2017
Medical Device Network
C2 Therapeutics:
Pentax Medical acquires C2 Therapeutics
Jan 09, 2017
C2 Therapeutics Blog
C2 Therapeutics Blog PENTAX Medical Expands Interventional Endoscopy Offering with Acquisition of C2 Therapeutics
Jun 07, 2016
C2 Therapeutics Blog
C2 Therapeutics Blog C2 Therapeutics Announces Initiation of Coldplay III Trial Validating The C2 CryoBalloon Focal Ablation System for Primary Treatment of Barrett's Esophagus
Jun 06, 2016
BioSpace
C2 Therapeutics: <b>C2 Therapeutics</b> Announces Initiation Of Coldplay III Trial Validating The C2 Cryoballoon Focal Ablation System For Primary Treatment Of Barrett???s Esophagus
May 24, 2016
Business Wire
Press Release: C2 Therapeutics : C2 Therapeutics Announces Data from Four Studies Reinforcing the Safety and Efficacy of Its C2 CryoBalloon Focal Ablation System
May 24, 2016
C2 Therapeutics Blog
C2 Therapeutics Blog C2 Therapeutics Announces Data from Four Studies Reinforcing the Safety and Efficacy of its C2 CryoBalloon Focal Ablation System
Jan 27, 2016
Medical Product Outsourcing
C2 Therapeutics: C2 Therapeutics Announces Leadership Team Expansion
Nov 12, 2015
MEDICAL PRODUCT OUTSOURCING
C2 Therapeutics: C2 Therapeutics' Focal Ablation System Performs Well in Recent Studies
Nov 10, 2015
BUSINESS WIRE
Press Release: C2 Therapeutics : C2 Therapeutics Announces New Data Confirming Efficacy and Safety of Coldplay CryoBalloon® Focal Ablation System to Treat Esophageal Disease
C2 Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10